Implications of Correlation Between PBRM1 and PD-L1 Expression in Renal Cell Carcinoma, Clear Cell Type

被引：0
|
作者：
Lee, Jieun [1 ]
Choe, Gheeyoung [1 ]
Lee, Kyu Sang [1 ]
机构：
[1] Seoul Natl Univ, Bundang Hosp, Seongnamsi, South Korea
来源：
MODERN PATHOLOGY | 2022年 / 35卷 / SUPPL 2期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
575
引用
收藏
页码：617 / 617
页数：1
相关论文
共 50 条
  • [41] Intratumoral expression of programmed death ligand 1 (PD-L1) in patients with clear cell renal cell carcinoma (ccRCC)
    M. Abbas
    S. Steffens
    M. Bellut
    H. Eggers
    A. Großhennig
    J. U. Becker
    G. Wegener
    A. J. Schrader
    V. Grünwald
    P. Ivanyi
    Medical Oncology, 2016, 33
  • [42] The Impact of PBRM1 Expression as a Prognostic and Predictive Marker in Metastatic Renal Cell Carcinoma
    Kim, Ji-Yeon
    Lee, Se-Hoon
    Moon, Kyung Chul
    Kwak, Cheol
    Kim, Hyeon Hoe
    Keam, Bhumsuk
    Kim, Tae Min
    Heo, Dae Seog
    JOURNAL OF UROLOGY, 2015, 194 (04): : 1112 - 1119
  • [43] PBRM1 and VHL expression correlate in human clear cell renal cell carcinoma with differential association with patient's overall survival
    Hoegner, Anica
    Krause, Hans
    Jandrig, Burkhard
    Kasim, Mumtaz
    Fuller, Tom Florian
    Schostak, Martin
    Erbersdobler, Andreas
    Patzak, Andreas
    Kilic, Ergin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (03) : 94.e1 - 94.e14
  • [44] Soluble PD-L1 Is an Independent Prognostic Factor in Clear Cell Renal Cell Carcinoma
    Larrinaga, Gorka
    Solano-Iturri, Jon Danel
    Errarte, Peio
    Unda, Miguel
    Loizaga-Iriarte, Ana
    Perez-Fernandez, Amparo
    Echevarria, Enrique
    Asumendi, Aintzane
    Manini, Claudia
    Angulo, Javier C.
    Lopez, Jose I.
    CANCERS, 2021, 13 (04) : 1 - 17
  • [45] PBRM1 and BAP1 as Novel Targets for Renal Cell Carcinoma
    Brugarolas, James
    CANCER JOURNAL, 2013, 19 (04): : 324 - 332
  • [46] Concomitant Loss of PBRM1 and BAP1 Protein Expression is an Important Prognostic Event in Early Stages of Clear Cell Renal Cell Carcinoma
    da Cunha, Isabela W.
    da Costa, Walter H.
    Fares, Aline F.
    Bezerra, Stephania M.
    Schultz, Luciana
    Guimaraes, Gustavo C.
    Zequi, Stenio C.
    LABORATORY INVESTIGATION, 2018, 98 : 336 - 336
  • [47] Loss of BAP1 and PBRM1 protein expression and its association with clear cell renal cell carcinoma-specific survival.
    Joseph, Richard Wayne
    Kapur, Payal
    Serie, Daniel
    Eckel-Passow, Jeanette
    Thai Huu Ho
    Brugarolas, James
    Parker, Alexander S.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [48] Role of Nivolumab in the Modulation of PD-1 and PD-L1 Expression in Papillary and Clear Cell Renal Carcinoma (RCC)
    Bialek, Joanna
    Yankulov, Stefan
    Kawan, Felix
    Fornara, Paolo
    Theil, Gerit
    BIOMEDICINES, 2022, 10 (12)
  • [49] Comparing the performance of three PD-L1 antibodies for PD-L1 expression in renal cell carcinoma
    Park, S.
    Wi, Y. C.
    Shin, S.
    Jang, K.
    VIRCHOWS ARCHIV, 2019, 475 : S181 - S182
  • [50] PD-L1 expression in primary clear cell renal cell carcinomas (ccRCCs) and their metastases
    Callea, Marcella
    Genega, Elizabeth M.
    Gupta, Mamta
    Fay, Andre P.
    Song, Jiaxi
    Carvo, Ingrid
    Bhatt, Rupal Satish
    McDermott, David F.
    Atkins, Michael B.
    Choueiri, Toni K.
    Freeman, Gordon J.
    Signoretti, Sabina
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
12345